A cleaner Ingevity finds new growth in water filtration
- The core profit engine is Performance Materials, where Q2 2026 segment EBITDA margins approached 54 percent.
- A new municipal water treatment contract for PFAS filtration opens a long-term growth market outside of automotive.
- The sale process for the Advanced Polymer Technologies segment reached an advanced stage in Q2 2026.
- Management has eliminated 10 million dollars of its 20 million dollar stranded cost reduction target.
- Higher asphalt prices are slowing international pavement projects, though North American volumes continue to grow.
The smaller company builds momentum
Ingevity is trying to become New Ingevity, a smaller and cleaner chemicals company built around two businesses: Performance Materials and Pavement Technologies. The bull case is that this plan makes the good parts easier to see. Performance Materials is highly profitable, and Q2 2026 got help from buyers choosing hybrid vehicles instead of battery electric vehicles. The recent completion of the industrial specialties and road markings sales proves management can execute the cleanup.
The company also secured its first municipal water treatment contract for PFAS filtration in Q2 2026. This is a critical development. It validates a new growth vector that does not depend on the auto cycle, which could eventually offset the long-term risk of full electric vehicle adoption.
The bear case remains focused on execution and raw material costs. Advanced Polymer Technologies, or APT, is in an advanced stage of being sold. A weak deal or no deal would keep the main execution risk alive. Additionally, higher asphalt prices have started to impact international road projects, introducing near-term headwinds for the Pavement Technologies segment.
High-margin carbon, road additives, and exits
Ingevity makes money by selling specialty chemical products to industrial customers. Its most valuable business is Performance Materials, which sells hardwood-based activated carbon used in gasoline vapor control systems and filtration. In Q2 2026, this segment saw EBITDA margins approach 54 percent, driven by price increases and hybrid vehicle demand.
Pavement Technologies sells additives and tools used in asphalt construction, preservation, and recycling. This business depends on road budgets, contractor activity, and the price of asphalt itself. It is set to be one of the two core pieces of New Ingevity.
The model can break if the simplification plan stalls. Road markings was sold to PPG for 65 million dollars, and industrial specialties for 93 million dollars. APT remains the bigger open item. If that sale fails, or if the remaining 10 million dollars of stranded costs stay in the business, the go-forward margin profile will look less clean than the bull case expects.
What stays, what goes
Automotive activated carbon
This is the core Performance Materials product line. It helps control gasoline vapor emissions in internal combustion and hybrid vehicles, and it drives very high segment margins.
Filtration activated carbon
Ingevity sells activated carbon for food, water, and chemical filtration. A new Q2 2026 municipal contract for PFAS water treatment validates this as a major growth vector.
Pavement Technologies
This product line sells asphalt additives and road technologies for construction, preservation, and recycling. It is a core part of New Ingevity, though sensitive to asphalt costs.
Advanced Polymer Technologies
APT makes caprolactone-based polymers used in end markets like automotive, footwear, and industrial products. The whole segment is in the advanced stages of a sale process.
Mix before the next sale
Segment shares use Q1 2026 net sales from continuing operations: Performance Materials 155.4 million dollars, Performance Chemicals 58.3 million dollars, and APT 44.3 million dollars. The mix will change when APT is sold.
What could still go wrong
APT sale disappoints
High impact · Medium oddsAPT is the largest remaining piece of the portfolio cleanup. The sale process is in an advanced stage, but a complex deal structure or weak end markets could reduce the value of any deal, or leave Ingevity owning a weaker business longer than planned.
Stranded costs stay too high
Medium impact · Medium oddsSelling businesses does not remove every related cost on day one. Ingevity must eliminate 20 million dollars of indirect costs from recent sales. It removed 10 million dollars by Q2 2026, but missing the rest would pressure New Ingevity margins.
EV shift cuts the carbon runway
High impact · Medium oddsPerformance Materials depends on internal combustion and hybrid vehicles because its carbon products control gasoline vapors. The business currently benefits from a consumer shift toward hybrids, but a faster move to battery electric vehicles would shrink the need for this product over time.
High asphalt prices limit pavement demand
Medium impact · Medium oddsHigher oil prices pushed asphalt prices up nearly 50 percent recently, which severely slowed international pavement opportunities in Q2 2026. If these high costs start delaying North American road projects, Pavement Technologies volume will suffer.
In one breath
What does Ingevity actually make?
Ingevity makes specialty chemical products. Its key products include activated carbon for gasoline vapor control and water filtration, asphalt additives for roads, and caprolactone-based polymers in APT.
Why is Ingevity selling businesses?
Management wants to create New Ingevity, a simpler company focused on higher-margin areas. It sold industrial specialties and road markings, and APT is in the advanced stages of a sale process.
Why do hybrid cars matter for NGVT?
Hybrids still use gasoline engines, so they need vapor control systems that use Ingevity activated carbon. That helps Performance Materials buy time while the company develops new markets like PFAS filtration.
What is the biggest near-term catalyst?
The biggest catalyst is a clear outcome for APT. A sale at a fair price would make the portfolio cleaner, while a weak deal or no deal would keep the main execution risk alive.
